CTEC · Pharma and healthcare · one day
Convatec (CTEC): news on Thursday 19 November 2026
News from the 24 hours to Thursday morning, 19 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage centred on Convatec lifting its revenue growth forecast, with shares jumping around 10%. A broker endorsement and upbeat valuation commentary added to the positive tone.
What drove it
- raised revenue guidance
- share price surge
- broker upgrade
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Fri 13 Nov | +0.7 | 2 |
| Tue 17 Nov | +5.0 | 2 |
| Wed 18 Nov | +4.7 | 2 |
| Thu 19 Nov | +10.0 | 4 |
2 stories · 4 headlines · strongest first
Pharma and healthcare on 19 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| Convatec lifts its revenue growth outlook for 2026 to 6.25%–7% +10.03 headlines today · Convatec lifted its outlook to 6.25–7% and shares jumped. | ||
| +10.0 | Sharp share price jump after improved sales guidance. | |
| +10.0 | Higher sales growth guidance driven by strength in two product areas. | |
| +7.5 | Valuation commentary sees shares reasonable given brighter sales expectations. | |
| UBS backs Convatec after growth acceleration +10.01 headline today · UBS sees further upside for the shares. | ||
| +10.0 | Broker endorsement sees more room for shares to rise. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated Convatec: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.